This Biotech Just Inched Closer To Treating 90% Of Cystic Fibrosis PatientsInvestors Business Daily • 05/30/19
Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $19.9 million of SharesGuruFocus • 05/29/19
Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/01/19
Cystic Fibrosis-Focused Biotech Easily Tops First-Quarter EstimatesInvestors Business Daily • 04/30/19